Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001827169-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | INDV | Ryan Barbara | Dir | P - Purchase | $32.56 | +31 | 5,716 | +0.5% | +$1,009 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | P | A | 31 | $32.56 | 5,716 | D | — | — |